Patents by Inventor Catherine Dacquet

Catherine Dacquet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic Oxime Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them
    Publication number: 20090274674
    Abstract: Compounds of formula (I): wherein: X represents a hydrogen or halogen atom or an alkyl group, R1, R2, R3 and R4 are as defined in the description, A represents an alkylene chain as defined in the description, B represents an alkyl or alkenyl group substituted by a group D represents a pyridine nucleus.
    Type: Application
    Filed: December 19, 2006
    Publication date: November 5, 2009
    Applicant: LES LABORATOIRES SERVIER
    Inventors: Franck Suzenet, Gerald Guillaumet, Christelle Pillard, Carine Bassene, Catherine Dacquet, Alain Ktorza, Daniel-Henri Caignard
  • Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them
    Publication number: 20090239917
    Abstract: Compounds of formula (I): wherein: R1 represents a (C3-C8)cycloalkyl group, R2 represents a group of formula (II) as defined in the description, X represents an oxygen atom or an N—OR? group wherein R? represents a hydrogen atom, a linear or branched (C1-C6)alkyl group, an aryl group or an aryl-(C1-C6)alkyl group in which the alkyl moiety may be linear or branched. Medicinal products containing the same which are useful as hypoglycaemic and hypolipaemic agents.
    Type: Application
    Filed: March 5, 2007
    Publication date: September 24, 2009
    Applicant: Les Laboratoires Servier
    Inventors: Aurelie Hurtevent, Jean-Martial L'Helgoual'ch, Pascal Carato, Nicolas Lebegue, Veronique Leclerc, Morgan Le Naour, Pascal Berthelot, Catherine Dacquet, Alain Ktorza, Daniel-Henri Caignard
  • Heterocyclic Oxime Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them.
    Publication number: 20080113974
    Abstract: Compounds of formula (I): wherein: X represents an oxygen atom or a sulphur atom, R1, R2, R3 and R4 are as defined in the description, A represents an alkylene chain as defined in the description, and B represents an alkyl or alkenyl group substituted by a group or R7, or B represents a group or R7.
    Type: Application
    Filed: January 26, 2006
    Publication date: May 15, 2008
    Applicant: LES LABORATOIRES SERVIER
    Inventors: Aurelie Hurtevent, Jean-Martial L' Helgoual' Ch, Pascal Carato, Nicolas Lebegue, Veronique Leclerc, Pascal Berthelot, Catherine Dacquet, Alain Ktorza, Daniel-Henri Caignard
  • Association between a heterocyclic compound and an antioxidant agent
    Publication number: 20070167502
    Abstract: A pharmaceutical composition for treatment of obesity associated with lipid and carbohydrate metabolism comprising (i) a substance which is useful in promoting lipid and carbohydrate metabolism, (ii) an antioxidant agent and, optionally, (iii) a pharmaceutically acceptable carrier or excipient, wherein the substance which promotes lipid and carbohydrate metabolism and the antioxidant agent are present in therapeutically effective dosages. Methods which are useful in treating conditions associated with obesity.
    Type: Application
    Filed: March 30, 2005
    Publication date: July 19, 2007
    Inventors: Louis Casteilla, Luc Penicaud, Pascal Berthelot, Catherine Dacquet, Daniel-Henri Caignard
  • Heterocyclic oxime compounds
    Patent number: 7071221
    Abstract: Compounds of formula (I): wherein: X represents oxygen or sulphur or a group CH2 or R1, R2, R3, R4, R5 and R6 are as defined in the description, A represents an alkylene chain as defined in the description, B represents alkyl or alkenyl substituted by a group ?or R9, or B represents a group ?or R9, D represents a benzene, pyridine, pyrazine, pyrimidine or pyridazine nucleus.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: July 4, 2006
    Assignee: Les Laboratoires Servier
    Inventors: Véronique Leclerc, Sylvie Pailloux, Pascal Carato, Carine Introvigne, Nicolas Lebegue, Pascal Berthelot, Catherine Dacquet, Jean Albert Boutin, Daniel Henri Caignard, Pierre Renard
  • Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity
    Publication number: 20060111407
    Abstract: The invention relates to a combination comprising a compound favouring lipid and carbohydrate metabolisms and an antioxidant agent and to pharmaceutical compositioins comprising the combination.
    Type: Application
    Filed: October 10, 2003
    Publication date: May 25, 2006
    Inventors: Louis Casteilla, Luc Penicaud, Pascal Rerthelot, Catherine Dacquet
  • Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
    Patent number: 6919362
    Abstract: Compounds of formula (I): wherein: X represents an oxygen or a sulphur or CH2 or R1 and R2 represent a hydrogen atom, or a group as defined in the description, A represents an alkylene chain as described in the description, B is as defined in the description, R3 and R4 represent a hydrogen atom or a group as defined in the description, D represents an optionally substituted benzene, optionally substituted pyrazine, optionally substituted pyrimidine or optionally substituted pyridazine and medicinal products containing the same which are useful in treating or preventing melatoninergic disorders.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: July 19, 2005
    Assignee: Les Laboratoires Servier
    Inventors: Daniel Lesieur, Elodie Blanc-Delmas, Said Yous, Patrick Depreux, Gérald Guillaumet, Catherine Dacquet, Nigel Levens, Jean Albert Boutin, Caroline Bennejean, Pierre Renard
  • New heterocyclic oxime compounds
    Publication number: 20050026973
    Abstract: Compounds of formula (I): wherein: X represents oxygen or sulphur or a group CH2 or R1, R2, R3, R4, R5 and R6 are as defined in the description, A represents an alkylene chain as defined in the description, B represents alkyl or alkenyl substituted by a group ?or R9, or B represents a group ?or R9, D represents a benzene, pyridine, pyrazine, pyrimidine or pyridazine nucleus.
    Type: Application
    Filed: July 29, 2004
    Publication date: February 3, 2005
    Inventors: Veronique Leclerc, Sylvie Pailloux, Pascal Carato, Carine Introvigne, Nicolas Lebegue, Pascal Berthelot, Catherine Dacquet, Jean Boutin, Daniel Caignard, Pierre Renard
  • Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
    Publication number: 20030040533
    Abstract: Compounds of formula (I): 1
    Type: Application
    Filed: August 2, 2002
    Publication date: February 27, 2003
    Inventors: Daniel Lesieur, Elodie Blanc-Delmas, Said Yous, Patrick Depreux, Gerald Guillaumet, Catherine Dacquet, Nigel Levens, Jean Albert Boutin, Caroline Bennejean, Pierre Renard